Compounding - a core competence of the pharmacist
Friday 2 October 2015
B6, 3 hours
Organised by the FIP Community Pharmacy Section and the FIP Industrial Pharmacy Section
Compounding is still a core competence of the pharmacists and has been offered by pharmacists over the last decades. The demand by patients and doctors for customised medication is growing, due to increasing drug shortages all over the world. But how to manage quality in preparations and how to guarantee the quality of the product in small scale production? This session will highlight the significance of knowledge management and risk management in quality assurance and give practical advice from practitioners to practitioners.
At the conclusion of this knowledge-based session, participants will be able to:
- Identify how to manage quality assurance in different dosage forms referring to specific patient groups or specific indications.
- Detect the significance of hygienic measurements to assure the microbiological quality of individual preparations.
- Distinguish different national experiences in external quality control in the context of a pharmaceutical quality management system related to retail pharmacies.
- Judge the benefit of a risk-based approach to preparation, in-process controls and quality testing.
- Identify benefits from cooperation between pharmacist and prescriber in compounding.
Chairs: Karin Graf (ABDA, Germany) and Holger Reimann (DAC/NRF, Germany)
14:30 1) Introduction
Sola Solarin (FIP IPS, United Kingdom)
14:35 2) Quality assurance in different dosage forms, patient groups and indications
a. Compounding for opioid replacement therapy, e.g. methadone preparation
Andreas Schmid (pharmasuisse, Switzerland)
b. Compounding for diseases of the eyes, nose and ears
Laurens Schulpen (Apotheek Woerden, The Netherlands)
15:15 3) Assuring the microbiological quality of individual preparations
Lisa Britta Schlegel (Zentrallaboratorium, Germany)
16:10 4) External quality control and certification of the pharmaceutical quality management system - the German way
Mona Tawab (Zentrallaboratorium, Germany)
16:50 5) To the best interest of the patient: pharmacist/prescriber cooperation in compounding
Maria Carvalho (Professional Compounding Centers of America - PCCA, Portugal)